Integrated Filing- Financial

IOL Chemicals and Pharmaceuticals has announced a board meeting on 12th February 2025, during which they reviewed and approved the financial results for the quarter and nine months ended 31st December 2024. The company reported a revenue from operations of ₹527.37 crore, resulting in a profit before tax of ₹27.80 crore.

Notably, the Board declared an interim dividend of ₹4 per share.

Furthermore, plans for a share split were confirmed, aimed at increasing liquidity and accessibility for investors.

This development may enhance investor sentiment by emphasizing growth and rewarding shareholders.